Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-07-08

Clinical Trial Update: Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital [Phase 4]

View source ↗

Summary

Phase 4 study investigating paliperidone palmitate versus selected oral antipsychotics in adults with schizophrenia recently discharged from inpatient care has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral antipsychotics (unspecified)
  • Paliperidone palmitate (Paliperidone palmitate)

Snippet

Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC | Conditions: Schizophrenia | Phase 4 | Status: WITHDRAWN